Parallax Health Sciences Inc (PRLX) financial statements (2020 and earlier)

Company profile

Business Address 1327 OCEAN AVENUE, SUITE M
SANTA MONICA, CA 90401
State of Incorp. NV
Fiscal Year End December 31
SIC 80 - Health Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 0363
Cash and cash equivalents 0363
Receivables  44838
Inventory, net of allowances, customer advances and progress billings   410
Inventory   410
Other undisclosed current assets  9104
Total current assets: 0551,415
Noncurrent Assets
Property, plant and equipment  1039
Long-term investments and receivables  170170
Accounts and financing receivable, after allowance for credit loss  170170
Intangible assets, net (including goodwill) 1,3643,083977
Goodwill 785785785
Intangible assets, net (excluding goodwill) 5792,298192
Deposits noncurrent assets   23
Other undisclosed noncurrent assets  22 
Total noncurrent assets: 1,3643,2851,209
TOTAL ASSETS: 1,3643,3402,624
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 2,6556,0273,974
Accounts payable 8312,0211,458
Accrued liabilities 2501,000 
Employee-related liabilities 40236845
Taxes payable  3835
Interest and dividends payable 4501,724804
Other undisclosed accounts payable and accrued liabilities 7228761,632
Debt 1,317741 
Derivative instruments and hedges, liabilities 24  
Due to related parties 1,0051,284425
Other undisclosed current liabilities 1151311
Total current liabilities: 5,1168,0654,410
Noncurrent Liabilities
Long-term debt and lease obligation 93418,46413,690
Long-term debt, excluding current maturities 93418,46413,690
Liabilities, other than long-term debt 5251,1671,357
Due to related parties 4911,1671,357
Derivative instruments and hedges, liabilities 34  
Other undisclosed noncurrent liabilities 7403,034740
Total noncurrent liabilities: 2,19922,66515,788
Total liabilities: 7,31530,73020,198
Stockholders' equity
Stockholders' equity attributable to parent, including: (5,950)6,54617,684
Preferred stock 111
Common stock 158137107
Common stock, value, subscriptions   (2)
Additional paid in capital 13,0816,2462,216
Deferred compensation equity (1,149)(1,810) 
Accumulated deficit (19,191)  
Warrants and rights outstanding  1,97215,362
Stockholders' equity note, subscriptions receivable  (1)(2)
Other undisclosed stockholders' equity attributable to parent 1,149  
Other undisclosed stockholders' equity  (33,935)(35,258)
Total stockholders' equity: (5,950)(27,390)(17,574)
TOTAL LIABILITIES AND EQUITY: 1,3643,3402,624

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Revenues 123,19522,749
Revenue, net3,19522,749
Cost of revenue
(Cost of Goods and Services Sold)
 (20)(3,226)(19,188)
Gross profit: (9)(31)3,561
Operating expenses (6,626)(7,087)(6,708)
Operating loss: (6,635)(7,118)(3,147)
Nonoperating income (expense) 22,243(6,758)(10,035)
Interest and debt expense 22,858 918
Income (loss) from continuing operations before income taxes: 38,466(13,877)(12,264)
Income tax expense  (3)(21)
Other undisclosed loss from continuing operations (22,858)  
Income (loss) from continuing operations: 15,608(13,879)(12,285)
Income (loss) from discontinued operations (824)954 
Income (loss) before gain (loss) on sale of properties: 14,784(12,925)(12,285)
Other undisclosed net income (loss) 824(951)(897)
Net income (loss): 15,608(13,877)(13,182)
Other undisclosed net loss attributable to parent (824)  
Net income (loss) available to common stockholders, diluted: 14,784(13,877)(13,182)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Net income (loss): 15,608(13,877)(13,182)
Comprehensive income (loss), net of tax, attributable to parent: 15,608(13,877)(13,182)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: